STERIS plc (STE)
Days of sales outstanding (DSO)
Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | ||
---|---|---|---|---|---|---|
Receivables turnover | 5.23 | 5.10 | 4.89 | 5.74 | 5.10 | |
DSO | days | 69.79 | 71.62 | 74.69 | 63.61 | 71.58 |
March 31, 2025 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ 5.23
= 69.79
Analyzing the days of sales outstanding (DSO) for STERIS plc over the period from March 31, 2021, to March 31, 2025, reveals the following trends:
1. STERIS plc's DSO as of March 31, 2021, stood at 71.58 days. This metric decreased to 63.61 days by March 31, 2022, indicating a favorable trend in collecting receivables more quickly.
2. However, the DSO increased to 74.69 days by March 31, 2023, which suggests a delay in converting sales into cash compared to the previous year.
3. By March 31, 2024, the DSO figure for STERIS plc reverted back to a similar level as in 2021, at 71.62 days, indicating a stabilization in the collection period.
4. Notably, as of March 31, 2025, specific data for the DSO is unavailable (denoted as "— days"), making it challenging to assess the company's receivables turnover efficiency in that period.
In summary, while STERIS plc demonstrated improvements in its DSO from 2021 to 2022, there was a subsequent increase in 2023, followed by a return to a similar level in 2024. However, the lack of data for 2025 restricts a complete evaluation of the company's collection efficiency in that period.
Peer comparison
Mar 31, 2025